Dhaliwal Harpreet S. 4
4 · Vaxcyte, Inc. · Filed Dec 30, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2022-12-28+3,990→ 96,010 totalExercise: $25.06Exp: 2031-11-07→ Common Stock (3,990 underlying) - Exercise/Conversion
Common Stock
2022-12-28$25.06/sh+3,990$99,989→ 21,808 total
Footnotes (2)
- [F1]Includes 928 shares acquired under the Vaxcyte, Inc. Employee Stock Purchase Plan on November 17, 2022.
- [F2]1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.